Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000546299 | SCV000651118 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000598569 | SCV000710044 | uncertain significance | not provided | 2018-08-17 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the FLNC gene. The G2130G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The G2130G variant is observed in 3/17246 (0.017%) alleles from individuals of East Asian background in large population cohorts (Lek et al., 2016). Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Ambry Genetics | RCV002367915 | SCV002661141 | likely benign | Cardiovascular phenotype | 2020-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |